Cargando…

Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1)

OBJECTIVES: Brain tumours lead to significant morbidity including a neurocognitive, physical and psychological burden of disease. The extent to which they impact the multiple domains of health is difficult to capture leading to a significant degree of unmet needs. Mobile health tools such as Vinehea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gvozdanovic, Andrew, Jozsa, Felix, Fersht, Naomi, Grover, Patrick James, Kirby, Georgina, Kitchen, Neil, Mangiapelo, Riccardo, McEvoy, Andrew, Miserocchi, Anna, Patel, Rayna, Thorne, Lewis, Williams, Norman, Kosmin, Michael, Marcus, Hani J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791405/
https://www.ncbi.nlm.nih.gov/pubmed/36579146
http://dx.doi.org/10.1136/bmjsit-2021-000130
_version_ 1784859400513519616
author Gvozdanovic, Andrew
Jozsa, Felix
Fersht, Naomi
Grover, Patrick James
Kirby, Georgina
Kitchen, Neil
Mangiapelo, Riccardo
McEvoy, Andrew
Miserocchi, Anna
Patel, Rayna
Thorne, Lewis
Williams, Norman
Kosmin, Michael
Marcus, Hani J
author_facet Gvozdanovic, Andrew
Jozsa, Felix
Fersht, Naomi
Grover, Patrick James
Kirby, Georgina
Kitchen, Neil
Mangiapelo, Riccardo
McEvoy, Andrew
Miserocchi, Anna
Patel, Rayna
Thorne, Lewis
Williams, Norman
Kosmin, Michael
Marcus, Hani J
author_sort Gvozdanovic, Andrew
collection PubMed
description OBJECTIVES: Brain tumours lead to significant morbidity including a neurocognitive, physical and psychological burden of disease. The extent to which they impact the multiple domains of health is difficult to capture leading to a significant degree of unmet needs. Mobile health tools such as Vinehealth have the potential to identify and address these needs through real-world data generation and delivery of personalised educational material and therapies. We aimed to establish the feasibility of Vinehealth integration into brain tumour care, its ability to collect real-world and (electronic) patient-recorded outcome (ePRO) data, and subjective improvement in care. DESIGN: A mixed-methodology IDEAL stage 1 study. SETTING: A single tertiary care centre. PARTICIPANTS: Six patients consented and four downloaded and engaged with the mHealth application throughout the 12 weeks of the study. MAIN OUTCOME MEASURES: Over a 12-week period, we collected real-world and ePRO data via Vinehealth. We assessed qualitative feedback from mixed-methodology surveys and semistructured interviews at recruitment and after 2 weeks. RESULTS: 565 data points were captured including, but not limited to: symptoms, activity, well-being and medication. EORTC QLQ-BN20 and EQ-5D-5L completion rates (54% and 46%) were impacted by technical issues; 100% completion rates were seen when ePROs were received. More brain cancer tumour-specific content was requested. All participants recommended the application and felt it improved care. CONCLUSIONS: Our findings indicate value in an application to holistically support patients living with brain cancer tumours and established the feasibility and safety of further studies to more rigorously assess this.
format Online
Article
Text
id pubmed-9791405
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-97914052022-12-27 Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1) Gvozdanovic, Andrew Jozsa, Felix Fersht, Naomi Grover, Patrick James Kirby, Georgina Kitchen, Neil Mangiapelo, Riccardo McEvoy, Andrew Miserocchi, Anna Patel, Rayna Thorne, Lewis Williams, Norman Kosmin, Michael Marcus, Hani J BMJ Surg Interv Health Technol Original Research OBJECTIVES: Brain tumours lead to significant morbidity including a neurocognitive, physical and psychological burden of disease. The extent to which they impact the multiple domains of health is difficult to capture leading to a significant degree of unmet needs. Mobile health tools such as Vinehealth have the potential to identify and address these needs through real-world data generation and delivery of personalised educational material and therapies. We aimed to establish the feasibility of Vinehealth integration into brain tumour care, its ability to collect real-world and (electronic) patient-recorded outcome (ePRO) data, and subjective improvement in care. DESIGN: A mixed-methodology IDEAL stage 1 study. SETTING: A single tertiary care centre. PARTICIPANTS: Six patients consented and four downloaded and engaged with the mHealth application throughout the 12 weeks of the study. MAIN OUTCOME MEASURES: Over a 12-week period, we collected real-world and ePRO data via Vinehealth. We assessed qualitative feedback from mixed-methodology surveys and semistructured interviews at recruitment and after 2 weeks. RESULTS: 565 data points were captured including, but not limited to: symptoms, activity, well-being and medication. EORTC QLQ-BN20 and EQ-5D-5L completion rates (54% and 46%) were impacted by technical issues; 100% completion rates were seen when ePROs were received. More brain cancer tumour-specific content was requested. All participants recommended the application and felt it improved care. CONCLUSIONS: Our findings indicate value in an application to holistically support patients living with brain cancer tumours and established the feasibility and safety of further studies to more rigorously assess this. BMJ Publishing Group 2022-12-22 /pmc/articles/PMC9791405/ /pubmed/36579146 http://dx.doi.org/10.1136/bmjsit-2021-000130 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Gvozdanovic, Andrew
Jozsa, Felix
Fersht, Naomi
Grover, Patrick James
Kirby, Georgina
Kitchen, Neil
Mangiapelo, Riccardo
McEvoy, Andrew
Miserocchi, Anna
Patel, Rayna
Thorne, Lewis
Williams, Norman
Kosmin, Michael
Marcus, Hani J
Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1)
title Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1)
title_full Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1)
title_fullStr Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1)
title_full_unstemmed Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1)
title_short Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1)
title_sort integration of a personalised mobile health (mhealth) application into the care of patients with brain tumours: proof-of-concept study (ideal stage 1)
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791405/
https://www.ncbi.nlm.nih.gov/pubmed/36579146
http://dx.doi.org/10.1136/bmjsit-2021-000130
work_keys_str_mv AT gvozdanovicandrew integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT jozsafelix integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT fershtnaomi integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT groverpatrickjames integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT kirbygeorgina integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT kitchenneil integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT mangiapeloriccardo integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT mcevoyandrew integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT miserocchianna integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT patelrayna integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT thornelewis integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT williamsnorman integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT kosminmichael integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1
AT marcushanij integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1